Does early physical therapy intervention reduce opioid burden and improve functionality in the management of chronic lower back pain?

The Mental Health Clinician
Shedrick MartinHarminder Sikand

Abstract

Chronic lower back pain is a leading cause of disability in US adults. Opioid use continues to be controversial despite the Centers for Disease Control and Prevention guidance on chronic pain management to use nonpharmacologic and nonopioid pharmacologic interventions. The objectives of the study were to assess the impact of early physical therapy (PT) intervention on improving functionality and reducing opioid burden in patients with chronic lower back pain. A single-center, retrospective chart review of patients receiving ≥6 PT visits and treated with either opioids first (OF) or PT first (PTF) therapy for chronic lower back pain were evaluated. Concomitant use of nonopioid and nonpharmacologic therapy was permitted. The Oswestry Disability Index (ODI), a survey measuring functionality, was recorded for PTF group. Pain scores and medication use including opioids were collected at treatment initiation and completion. One hundred and eighty patients were included in three groups: OF group (n = 60), PTF group (n = 60), and PTF + ODI group (n = 60). The PTF + ODI group had mean ODI reduction of 11.9% (P < .001). More OF patients were lost to follow up (68.3%) or failed PT (60%) compared to the PTF group, 38.3% and 3.3% (P < .001)...Continue Reading

References

Apr 6, 2004·The Orthopedic Clinics of North America·C G Maher
Feb 11, 2009·Archives of Internal Medicine·Janet K FreburgerTimothy S Carey
Apr 3, 2009·The Journal of Bone and Joint Surgery. American Volume·Cindy L KidnerRobert J Gatchel
Nov 7, 2009·General Hospital Psychiatry·Jennifer Brennan BradenMichael Von Korff
Jan 20, 2010·Annals of Internal Medicine·Kate M DunnMichael Von Korff
Jul 20, 2010·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·Marienke van MiddelkoopMaurits W van Tulder
Apr 13, 2011·Archives of Internal Medicine·Tara GomesDavid N Juurlink
Nov 17, 2011·Journal of the American Board of Family Medicine : JABFM·Richard A DeyoSteven K Dobscha
Mar 8, 2012·JAMA : the Journal of the American Medical Association·Karen H SealThomas C Neylan
Nov 3, 2012·The Journal of Pain : Official Journal of the American Pain Society·Amy M KobusRichard A Deyo
Jul 12, 2013·JAMA : the Journal of the American Medical Association·Christopher J L MurrayUNKNOWN U.S. Burden of Disease Collaborators
Jan 15, 2014·PM & R : the Journal of Injury, Function, and Rehabilitation·Ming-Chih Jeffrey KaoMatthew Smuck
Apr 22, 2015·American Journal of Preventive Medicine·Benjamin LevyChristopher M Jones
Sep 1, 2015·Physical Therapy·Julie M FritzJosette Dorius
Jan 13, 2016·Journal of General Internal Medicine·Erin E KrebsUNKNOWN Osteoporotic Fractures in Men (MrOS) Study Research Group
Mar 18, 2016·MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports·Deborah DowellRoger Chou
Jun 15, 2016·JAMA : the Journal of the American Medical Association·Jane C Ballantyne
Nov 7, 2017·Best Practice & Research. Clinical Rheumatology·Neil E O'ConnellStephen P Ward

❮ Previous
Next ❯

Software Mentioned

SPSS®

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.